Who should be treated? The ethical challenges of administering opioid agonist treatment (OAT) for people who inject drugs during COVID-19

This project addresses the ethical challenges of modifications in opioid agonist treatment (OAT) during the COVID-19 pandemic for people who inject drugs. While several public health ethics frameworks exist, due to the novelty of the pandemic and treatment needs of PWID, little is known regarding their applicability to OAT. Drawing on the lived experiences of patients, healthcare providers and health administrators in San Juan, Puerto Rico, Dr. Abadie and his team will seek to develop an evidence-based, population tailored ethical framework for the administration of OAT for current and future infectious disease crises.